Prescription drug · ANDA
Mesna NDC 50742-354
Mesna 400 mg/1 · Tablet, Film coated · Oral · Ingenus Pharmaceuticals, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50742-354-01 | 50742035401 | 1 BLISTER PACK in 1 CARTON (50742-354-01) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Jan 14, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Mesna
- Generic name (nonproprietary)
- mesna
- Active ingredients
- Mesna — 400 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Ingenus Pharmaceuticals, LLCNDC labeler code 50742
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218871
- Marketing start
- Listing expires
- Identifiers
- Product ID 50742-354_ea85fa84-18f7-4b89-b701-1d9dc01a8e0dSPL ID ea85fa84-18f7-4b89-b701-1d9dc01a8e0dSPL set ID 90d64539-33ad-47e8-9de7-17d6c5baaba4RxCUI 142113UNII NR7O1405Q9UPC 0350742354016
- Pharmacologic class
- Cytoprotective Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450742035401followed by a unit qualifier and the quantityPackage 50742-0354-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Mesna is indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis. Limitation of Use: Mesna is not indicated to reduce the risk of hematuria due to other pathological conditions such as thrombocytopenia. Mesna is a cytoprotective agent indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis. ( 1 ) Limitation of Use: Mesna is not indicated to reduce the risk of hematuria due to other pathological conditions such as thrombocytopenia. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 50742-354
- What is NDC 50742-354?
- 50742-354 is the product NDC for Mesna, Mesna 400 mg/1 tablet, film coated, listed with the FDA by Ingenus Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Mesna.
- What is the active ingredient?
- Mesna.
- Who is the labeler?
- Ingenus Pharmaceuticals, LLC, NDC labeler code 50742. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Mesna?
- 7 other product NDCs are listed under this name. See all Mesna NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Mesna products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Eugia US LLC | 55150-520 | 55150-0520-01 |
| Mesnamesna injection | Mesna 100 mg/mL | SolutionIntravenous | Gland Pharma Limited | 68083-161 | 68083-0161-0168083-0161-10 |
| Mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Sagent Pharmaceuticals | 25021-201 | 25021-0201-1025021-0201-11 |
| mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9260 | 00143-9260-01 |
| Mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-733 | 63323-0733-1063323-0733-11 |
| Mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Baxter Healthcare Company | 10019-951 | 10019-0951-05 |
| Mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Baxter Healthcare Company | 10019-953 | 10019-0953-0110019-0953-02 |